2vr3: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2vr3.png|left|200px]] | |||
[[Image:2vr3. | |||
<!-- | <!-- | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
[[2vr3]] is a 4 chain structure of [[Fibrinogen]] with sequence from [http://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VR3 OCA]. | |||
==See Also== | |||
*[[Fibrinogen]] | |||
==Reference== | ==Reference== | ||
| Line 42: | Line 44: | ||
[[Category: Staphylococcus aureus]] | [[Category: Staphylococcus aureus]] | ||
[[Category: Virulence]] | [[Category: Virulence]] | ||
Revision as of 00:55, 27 December 2010
STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF FIBRINOGEN BINDING TO CLFA FROM STAPHYLOCCCUS AUREUS
Template:ABSTRACT PUBMED 19043557
About this Structure
2vr3 is a 4 chain structure of Fibrinogen with sequence from Staphylococcus aureus. Full crystallographic information is available from OCA.
See Also
Reference
- Ganesh VK, Rivera JJ, Smeds E, Ko YP, Bowden MG, Wann ER, Gurusiddappa S, Fitzgerald JR, Hook M. A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. PLoS Pathog. 2008 Nov;4(11):e1000226. Epub 2008 Nov 28. PMID:19043557 doi:10.1371/journal.ppat.1000226
